<--- Back to Details
First PageDocument Content
Health / Microbiology / Vaccination / Vaccines / Anthrax vaccines / Biodefense / Public Readiness and Emergency Preparedness Act / H5N1 clinical trials / Biology / Anthrax / Biological warfare
Date: 2014-08-23 01:19:30
Health
Microbiology
Vaccination
Vaccines
Anthrax vaccines
Biodefense
Public Readiness and Emergency Preparedness Act
H5N1 clinical trials
Biology
Anthrax
Biological warfare

National Biodefense Science Board Letter Re: Stockpiled Anthrax Vaccine Adsorbed (AVA) to Provide Post-Exposure Prophylaxis (PEP) for At-Risk Populations Following an Anthrax Attack

Add to Reading List

Source URL: www.phe.gov

Download Document from Source Website

File Size: 24,55 KB

Share Document on Facebook

Similar Documents

Microsoft Word - WEBSITE PHASE I RESULT-BARCELONA.doc

Microsoft Word - WEBSITE PHASE I RESULT-BARCELONA.doc

DocID: 1q51G - View Document

Microsoft Word - WEBSITE ABL NIAID  HBI collaboration.doc

Microsoft Word - WEBSITE ABL NIAID HBI collaboration.doc

DocID: 1q4Aa - View Document

Microsoft Word - EDUFLUVAC_PR_KoM_final_long_131120

Microsoft Word - EDUFLUVAC_PR_KoM_final_long_131120

DocID: 1njHg - View Document

© 2006 Nature Publishing Group http://www.nature.com/naturemedicine  BOOK REVIEW A successful vaccine that missed its target

© 2006 Nature Publishing Group http://www.nature.com/naturemedicine BOOK REVIEW A successful vaccine that missed its target

DocID: 1g1wb - View Document

Clinical trials charts_091014

Clinical trials charts_091014

DocID: 1g0qO - View Document